Lower riskDrug recall · FDA · Published January 27, 2023
Verapamil 120mg Tablets Recall: Failed Dissolution Test Risk
Amerisource Health Services recalls 120mg Verapamil Hydrochloride Extended-Release Tablets due to failed dissolution testing. This may affect medication effectiveness. Check NDC 60687-493-01 for affected lots.
Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.
Take action
Contact the company
📍Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer
Amerisource Health Services is recalling 120mg Verapamil Hydrochloride Extended-Release Tablets because they failed dissolution testing. This could mean the medication doesn't work as intended, which is serious for people needing blood pressure control. Read more at govinfonow.com/recall/33994-verapamil-120mg-tablets-recall-failed-dissolution-test-risk.
“Verapamil 120mg Tablets Recall: Failed Dissolution Test Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/33994-verapamil-120mg-tablets-recall-failed-dissolution-test-risk. Based on FDA recall #D-0436-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0436-2023%22&limit=1).
The FDA announced on Jan. 27, 2023, that Amerisource Health Services LLC voluntarily recalled Verapamil Hydrochloride Extended-Release Tablets due to failed dissolution specifications. The recall affects 422 cartons distributed nationwide.
How to tell if you have it
Brand: Amerisource Health
Product: Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only
Packaging: 100 Tablets per Carton (10 x 10)
Distributed by: American Health Packaging, Columbus, Ohio 43217
NDC Carton: 60687-493-01
NDC Unit Dose: 60687-493-11
Lot Code: 1009065
Expiration Date: 12/31/2023
Quantity: 422 cartons
The hazard
The tablets failed dissolution specifications, showing out-of-specification results at time point zero where values were above the specified limits. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Amerisource Health Services LLC has 30 other recalls on record since July 27, 2022. Other recent recalls of similar products include Amerisource Health Primidone Tablets Recall (May 1, 2026), Meclizine 12.5mg Tablets Recall (March 16, 2026), and Oxycodone 5mg Tablets Recall (Jan. 14, 2026). Other recent recalls of similar products include Teva Metoprolol Succinate Tablets Recall (Jan. 29, 2026), Teva Metoprolol Succinate Extended-Release Tablets Recall (Jan. 29, 2026), and Ascend Minocycline Tablets Recall (June 1, 2026).
How to tell if you have this one
Check for NDC Carton number 60687-493-01 and Lot 1009065 on the packaging. The tablets are 120mg extended-release, prescription-only, and come in 100-count cartons.
Brand
Amerisource Health Services
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for NDC Carton 60687-493-01 and Lot 1009065 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The recall is due to failed dissolution testing, which may affect medication effectiveness. The manufacturer has not stated that taking the medication causes harm.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0436-2023 (January 27, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0436-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.